The EDC is live today — see what ships now
All studies
NCT05156398From ClinicalTrials.govRecruiting

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents ≥ 6 to <18 Years of Age

  • Migraine

At a glance

Phase
Phase 3
Study type
Interventional
Sponsor
Pfizer
Enrolment target
640
Started
28 February 2022
Main results due
27 March 2029
Study sites
93
Registry updated
28 September 2026

Can you take part?

  • Ages 6 years to 17 years.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

1. Subject has at least a 6 month history of migraine (with or without aura) and including the following:

   1. 14 or less headache days per month during the 3 month period prior to the Screening Visit
   2. 6 or more migraine days during the Observation Period
   3. 14 or less headache days during the Observation Period
   4. Pediatric Migraine Disability Assessment Scale (PedMIDAS) Disability Score of \>10 to ≤50, indicating mild (score of 11 to 30) or moderate (score of 31 to 50) disruption in daily activities, as assessed at the Baseline (Randomization) Visit
   5. Ability to verbally distinguish migraine attacks from tension/cluster or other types of headaches
   6. Migraine attacks, on average, lasting 4 - 72 hours if untreated
   7. Subjects on prophylactic migraine medication are permitted to remain on therapy if the dose has been stable for at least 3 months (12 weeks) prior to the Screening Phase, and the dose is not expected to change during the course of the study. 2) Male and female subjects ≥ 6 to \<18 years; subjects must be less than 18 at the time of signing assent / consent.

      3)Subjects must have a weight of ≥40 kg (child cohort requirement ≥15 kg) at the Screening Visit.

Exclusion Criteria:

1. Subjects with a history of basilar migraine, cluster headaches, or hemiplegic migraine
2. The subject has a continuous migraine (defined as an unrelenting headache) within 1 month prior to Screening Visit.
3. The subject has a history or diagnosis of complications of migraine
4. The subject has a confounding and clinically significant pain syndrome that may interfere with the subject's ability to participate in this study.
5. The subject has any current psychiatric condition that is uncontrolled and/or untreated for a minimum of 6 months prior to the Screening Visit. Subjects with a lifetime history of psychosis and/or mania are excluded.
6. History of suicidal behavior or the subject is at risk of self-harm or harm to others.
7. History of major psychiatric disorder.
8. The subject has a current diagnosis or history of substance abuse
9. The subject has a history of moderate or severe head trauma or other neurological disorder (including seizure disorder) or systemic medical disease that is, in the investigator's opinion, likely to affect central nervous system functioning.

What this study is about

In the sponsor’s own words, from the registry.

The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine.

Study sites(93)

  • The Belinga Clinic

    Fort Smith, Arkansas, United States

    Active, not recruiting

  • Advanced Investigative Medicine, Inc.

    Hawthorne, California, United States

    Recruiting

  • Velocity Clinical Research San Diego

    La Mesa, California, United States

    Active, not recruiting

  • Colorado Springs Neurological Associates

    Colorado Springs, Colorado, United States

    Active, not recruiting

  • Advanced Neurosciences Research, LLC

    Fort Collins, Colorado, United States

    Terminated

  • Velocity Clinical Research, Washington DC

    Washington D.C., District of Columbia, United States

    Recruiting

  • Accel Research Sites Network - Edgewater Clinical Research Unit

    Edgewater, Florida, United States

    Active, not recruiting

  • Direct Helpers Research Center

    Hialeah, Florida, United States

    Recruiting

  • New Med Research, Inc

    Hollywood, Florida, United States

    Terminated

  • Complete Health Research

    Ormond Beach, Florida, United States

    Active, not recruiting

  • D&H Tamarac Research Center LLC

    Tamarac, Florida, United States

    Recruiting

  • Santos Research Center, CORP

    Tampa, Florida, United States

    Recruiting

  • Clinical Trial Office

    Augusta, Georgia, United States

    Recruiting

  • Augusta University

    Augusta, Georgia, United States

    Recruiting

  • WR-Mount Vernon Clinical Research, LLC

    Sandy Springs, Georgia, United States

    Active, not recruiting

  • Meridian Clinical Research, LLC

    Savannah, Georgia, United States

    Active, not recruiting

  • Extraordinary Family Healthcare

    Snellville, Georgia, United States

    Active, not recruiting

  • Renew Health Clinical Research LLC

    Snellville, Georgia, United States

    Active, not recruiting

  • Northwest Clinical Trials, Inc.

    Boise, Idaho, United States

    Recruiting

  • Diamond Headache Clinic

    Chicago, Illinois, United States

    Terminated

  • Nola Research Works, LLC

    New Orleans, Louisiana, United States

    Recruiting

  • NRST - Detroit

    Detroit, Michigan, United States

    Not yet recruiting

  • Clinical Research Institute

    Minneapolis, Minnesota, United States

    Not yet recruiting

  • Safe Haven Clinical Research

    Clinton, Mississippi, United States

    Terminated

  • Roy Blunt NextGen Precision Health Building

    Columbia, Missouri, United States

    Recruiting

  • University of Missouri Health Care - Investigation Pharmacy

    Columbia, Missouri, United States

    Recruiting

  • University of Missouri-Clinical and Translational Sciences Unit

    Columbia, Missouri, United States

    Recruiting

  • University of Missouri

    Columbia, Missouri, United States

    Recruiting

  • Velocity Clinical Research, Grand Island

    Grand Island, Nebraska, United States

    Recruiting

  • Papillion Research Center/CCT Research

    Papillion, Nebraska, United States

    Recruiting

  • Renown Regional Medical Center

    Reno, Nevada, United States

    Active, not recruiting

  • Dent Neurosciences Research Center, Inc.

    Amherst, New York, United States

    Active, not recruiting

  • Montefiore Medical Center

    The Bronx, New York, United States

    Recruiting

  • Carolina Institute for Clinical Research, LLC

    Fayetteville, North Carolina, United States

    Active, not recruiting

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, United States

    Recruiting

  • Velocity Clinical Research

    Cincinnati, Ohio, United States

    Active, not recruiting

  • Lynn Health Science Institute

    Oklahoma City, Oklahoma, United States

    Active, not recruiting

  • Coastal Pediatric Research

    Charleston, South Carolina, United States

    Active, not recruiting

  • Tribe Clinical Research LLC

    Greenville, South Carolina, United States

    Terminated

  • Avera McKennan Hospital & University Health Center

    Sioux Falls, South Dakota, United States

    Recruiting

  • Avera Research Institute

    Sioux Falls, South Dakota, United States

    Recruiting

  • Avera Medical Group Pediatrics - Dawley Farm

    Sioux Falls, South Dakota, United States

    Recruiting

  • Monroe Carell Jr Children's Hospital at Vanderbilt

    Nashville, Tennessee, United States

    Terminated

  • Alina Clinical Trials, LLC.

    Dallas, Texas, United States

    Recruiting

  • North Texas Center for Clinical Research

    Frisco, Texas, United States

    Recruiting

  • DM Clinical Research - Cy Fair

    Houston, Texas, United States

    Recruiting

  • SCLA Management - Drop Box

    Houston, Texas, United States

    Recruiting

  • SCLA Management Office

    Houston, Texas, United States

    Recruiting

  • NeuroCare Plus

    Houston, Texas, United States

    Recruiting

  • Red Star Research, LLC

    Lake Jackson, Texas, United States

    Active, not recruiting

  • DCT-McAllen Primary Care Research, LLC dba Discovery Clinical Trials

    McAllen, Texas, United States

    Recruiting

  • DCT-Stone Oak, LLC dba Discovery Clinical Trials

    San Antonio, Texas, United States

    Recruiting

  • Texas Institute for Neurological Disorders

    Sherman, Texas, United States

    Active, not recruiting

  • DM Clinical Research (Administrative Office Only)

    Tomball, Texas, United States

    Recruiting

  • Victoria Clinical Research Group

    Victoria, Texas, United States

    Terminated

  • Meridian Clinical Research, LLC

    Portsmouth, Virginia, United States

    Active, not recruiting

  • Children's and Women's Health Centre of British Columbia

    Vancouver, British Columbia, Canada

    Terminated

  • Centre Hospitalier Intercommunal de Creteil

    Créteil, France

    Recruiting

  • Centre Hospitalier Universitaire de Montpellier

    Montpellier, France

    Active, not recruiting

  • Hopital des Enfants

    Toulouse, France

    Recruiting

Showing 60 of 93 sites — filter to narrow it down. 61 of the 93 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT05156398. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects | Trialion